1-8 of 8
Pierre Sesques
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcome of patients with large B-cell lymphoma treated with tafasitamab plus lenalidomide either before or after CAR T-cell therapy

Vincent Camus, Roch Houot, Gabriel Brisou, Benoit Tessoulin, Sébastien Bailly, Pierre Sesques, Justine Decroocq, Daphné Krzisch, Lucie Oberic, François Lemonnier, Krimo Bouabdallah, Arnaud Campidelli, Ledraa Tounes, Julie Abraham, Charles Herbaux, Franck Morschhauser, Gandhi Laurent Damaj, Stéphanie Guidez, Sylvain Carras, Luc-Matthieu Fornecker, Sylvain Choquet, Olivier Hermine, Jérome Paillassa, Adrien Chauchet, Olivier Casasnovas, Laurianne Drieu La Rochelle, Cristina Castilla-Llorente, Magalie Joris, Vivien Dupont, Alexandra Marquet, Steven Le Gouill, Fabrice Jardin
Journal: Blood Advances
Blood Adv (2024) 8 (20): 5371–5381.
https://doi.org/10.1182/bloodadvances.2024013726
Published: 2024
Includes: Supplemental data
Journal Articles

Identification of primary mediastinal B-cell lymphomas with higher clonal dominance and poorer outcome using 5' RACE

Vincent Camus, Mathieu Viennot, Pierre-Julien Viailly, Fanny Drieux, Elena-Liana Veresezan, Victor Bobée, Vinciane Rainville, Elodie Bohers, Pierre Sesques, Corinne Haioun, Eric Durot, Michael Bayaram, Cédric Rossi, Laurent Martin, Dominique Penther, Sophie Kaltenbach, Julie Bruneau, Jérôme Paillassa, Olivier Tournilhac, Nicolas Gower, Alexandre Willaume, Chloe Antier, Loïc Renaud, Emilie Leveque, Pierre Decazes, Stéphanie Becker, David Tonnelet, Philippe GAULARD, Hervé Tilly, Thierry Molina, Alexandra Traverse-Glehen, Marie Donzel, Philippe Ruminy, Fabrice Jardin
Journal: Blood Advances
Blood Adv bloodadvances.2024013723.
https://doi.org/10.1182/bloodadvances.2024013723
Published: 2024
Includes: Supplemental data
Journal Articles

High PDL1/PDL2 gene expression correlates with worse outcome in primary mediastinal large B-cell lymphoma

Vincent Camus, Pierre-Julien Viailly, Fanny Drieux, Elena-Liana Veresezan, Pierre Sesques, Corinne Haioun, Eric Durot, Martine Patey, Cédric Rossi, Laurent Martin, Vinciane Rainville, Elodie Bohers, Philippe Ruminy, Dominique Penther, Sophie Kaltenbach, Julie Bruneau, Jérome Paillassa, Olivier Tournilhac, Alexandre Willaume, Chloé Antier, Julien Lazarovici, Emilie Lévêque, Pierre Decazes, Stéphanie Becker, David Tonnelet, Alina Berriolo-Riedinger, Philippe Gaulard, Hervé Tilly, Thierry Jo Molina, Alexandra Traverse-Glehen, Fabrice Jardin
Journal: Blood Advances
Blood Adv (2023) 7 (23): 7331–7345.
https://doi.org/10.1182/bloodadvances.2023011169
Published: 2023
Includes: Supplemental data
Journal Articles

Nonrelapse mortality after CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registry

Clinical Trials & Observations
Jean Lemoine, Emmanuel Bachy, Guillaume Cartron, David Beauvais, Thomas Gastinne, Roberta Di Blasi, Marie-Thérèse Rubio, Stéphanie Guidez, Mohamad Mohty, Rene-Olivier Casasnovas, Magalie Joris, Cristina Castilla-Llorente, Corinne Haioun, Olivier Hermine, Michael Loschi, Sylvain Carras, Pierre Bories, Tom Fradon, Charles Herbaux, Pierre Sesques, Steven Le Gouill, Franck Morschhauser, Catherine Thieblemont, Roch Houot
Journal: Blood Advances
Blood Adv (2023) 7 (21): 6589–6598.
https://doi.org/10.1182/bloodadvances.2023010624
Published: 2023
Includes: Supplemental data
Journal Articles

HLA-DR expression on monocytes and outcome of anti-CD19 CAR T-cell therapy for large B-cell lymphoma

Estelle Bourbon, Pierre Sesques, Morgane Gossez, Jérémie Tordo, Emmanuelle Ferrant, Violaine Safar, Florent Wallet, Guillaume Aussedat, Alizée Maarek, Fadhela Bouafia, Lionel Karlin, Dana Ghergus, Camille Golfier, Hélène Lequeu, Anne Lazareth, Vérane Schwiertz, Sébastien Viel, Maryam Idlhaj, Hervé Ghesquières, Guillaume Monneret, Emmanuel Bachy, Fabienne Venet
Journal: Blood Advances
Blood Adv (2023) 7 (5): 744–755.
https://doi.org/10.1182/bloodadvances.2021006563
Published: 2023
Includes: Supplemental data
Journal Articles

Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy

Kai Rejeski, Andreas Burchert, Gloria Iacoboni, Pierre Sesques, Lars Fransecky, Veit Bücklein, Corinna Trenker, Rafael Hernani, Ralph Naumann, Jonas Schäfer, Viktoria Blumenberg, Christian Schmidt, Kristina Sohlbach, Michael von Bergwelt-Baildon, Emmanuel Bachy, Pere Barba, Marion Subklewe
Journal: Blood Advances
Blood Adv (2022) 6 (16): 4719–4725.
https://doi.org/10.1182/bloodadvances.2022007776
Published: 2022
Includes: Supplemental data
Journal Articles

Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study

Clinical Trials & Observations
Vincent Camus, Cédric Rossi, Pierre Sesques, Justine Lequesne, David Tonnelet, Corinne Haioun, Eric Durot, Alexandre Willaume, Martin Gauthier, Marie-Pierre Moles-Moreau, Chloé Antier, Julien Lazarovici, Hélène Monjanel, Sophie Bernard, Magalie Tardy, Caroline Besson, Laure Lebras, Sylvain Choquet, Katell Le Du, Christophe Bonnet, Sarah Bailly, Ghandi Damaj, Kamel Laribi, Hervé Maisonneuve, Roch Houot, Adrien Chauchet, Fabrice Jardin, Alexandra Traverse-Glehen, Pierre Decazes, Stéphanie Becker, Alina Berriolo-Riedinger, Hervé Tilly
Journal: Blood Advances
Blood Adv (2021) 5 (19): 3862–3872.
https://doi.org/10.1182/bloodadvances.2021004778
Published: 2021
Includes: Supplemental data
Journal Articles

Clinicopathological features and survival in EBV-positive diffuse large B-cell lymphoma not otherwise specified

Clinical Trials & Observations
Estelle Bourbon, Delphine Maucort-Boulch, Juliette Fontaine, Claire Mauduit, Pierre Sesques, Violaine Safar, Emmanuelle Ferrant, Camille Golfier, Dana Ghergus, Lionel Karlin, Anne Lazareth, Fadhela Bouafia, Gian Matteo Pica, Frédérique Orsini-Piocelle, Clément Rocher, François-Xavier Gros, Marie Parrens, Arthur Dony, Cédric Rossi, Hervé Ghesquières, Emmanuel Bachy, Alexandra Traverse-Glehen, Clémentine Sarkozy
Journal: Blood Advances
Blood Adv (2021) 5 (16): 3227–3239.
https://doi.org/10.1182/bloodadvances.2021004515
Published: 2021
Includes: Supplemental data